HMGCR and benign prostatic hyperplasia: Consistent with these computational predictions, over-expression of c-Fos, n-Myc and Max in CHO cells augmented the BPL-Hmgcr promoter activity to a greater extent than the BPH-Hmgcr promoter (Fig. 9).